Mobile diagnostics Opportunity to position as a cost effective, portable coagulation testing solution for pre-hospital and in-transit care, enabling hospitals to receive actionable data before patient arrival and optimize blood product selection.

Early market entry Small team with funding of a few hundred thousand and current revenue under one million suggests a focused go-to-market with targeted pilots in trauma centers and surgical ICUs to validate the mobile lab concept.

Integrated data flow Leverage the technology stack and cloud tools to offer seamless data transmission to hospital systems, enabling real-time decision support and potential upsell of connected diagnostics and monitoring services.

Cost leadership Position as an inexpensive alternative to traditional coagulation assays for critical care, highlighting total cost of ownership benefits for hospitals and emergency departments.

Strategic partnerships Target collaborations with large medical device manufacturers or distributors serving trauma, surgery, and critical care to accelerate adoption and scale leveraging existing sales networks.